CrossrefInfo card
CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A
Journal of Cancer · 2026-01-01 · 17 (1) · 99-108
DOI: 10.7150/jca.118395 ↗Abstract
No abstract available.
EUVIMEDExplore EUVIMEDJournal of Cancer · 2026-01-01 · 17 (1) · 99-108
DOI: 10.7150/jca.118395 ↗No abstract available.
From a free start through personal literature research to the complete Research Suite.
View plans →No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.